Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Roshini Claire Anthony speaks to Dr Adoree Lim, a consultant at the Department of Endocrinology, Singapore General Hospital, on how GPs can help tackle hyper- and hypothyroidism in the primary care setting.
With the rise in life expectancy and the nation’s fixation with all things sweet, it is no wonder type 2 diabetes is now one of the country’s biggest health worries. The National Health and Morbidity Survey (NHMS) 2015 places the prevalence of type 2 diabetes at 17.5%. With such a high burden of disease, patient care and education can take its toll on the healthcare system. It falls upon the shoulders of healthcare personnel to ensure complications are minimized and targets are met. Here, the role diabetes educators play in the care of people with diabetes can help stem the tide of type 2 diabetes and its impending outcome on the healthcare system.
A 55-year-old man presented with almost one year history of heat intolerance, mild palpitation and significant weight loss. Free T3 and T4 were elevated with normal TSH. Patient had suboptimal response to carbimazole therapy.
Spinal fractures are often the result of underlying osteoporosis. Radha Chitale spoke with Dr. Hee Hwan Tak, medical director and senior consultant at the Pinnacle Spine & Scoliosis Centre at Mount Elizabeth Medical Centre, about managing osteoporotic spinal fractures in primary care.
This case scenario was presented at a grand round in the Department of Medicine, The University of Hong Kong. Unlike traditional grand rounds that directly or indirectly deal with clinical challenges posed by patients, this one was equally about doctors and how they care for their charges. All doctors who tend patients dread being implicated on the receiving end of medico-legal proceedings. This topic is therefore intimately linked to the professionalism of doctors, their standing in the community, and the ethical aspects of how they interact with patients and relatives.
During the recent Malaysian Endocrine and Metabolic Society’s 7th Annual Congress, two teams of endocrinologists gave their take on the motion of ‘A1c target of 7% as expounded by the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) is more pragmatic than the target of 6.5% recommended by the Malaysian CPG for T2DM, AACE and IDF.’
Melasma is a benign pigmentary skin disorder. However, it features prominently on sun-exposed areas, typically the face and arms, and as such affects the quality of life of those with the disorder. Radha Chitale spoke with Dr. Gavin Ong Chun Wei, a dermatologist at The Skin Specialist clinic in Singapore, about how GPs can best diagnose and treat patients with melasma.
Dr. Cheah Yee Lee, a liver transplant and hepatopancreatobiliary surgeon at Gleneagles Hospital, Singapore spoke to Roshini Claire Anthony on how GPs can help with early detection of pancreatic cancer and improve outcomes for patients.
Laparoscopic sleeve gastrectomy (SG) appears to be effective in Asians, with early weight loss correlating with midterm weight maintenance and remission of obesity-related comorbidities 1 year after the surgery, according to a study.
Short-term supplementation of palm-based tocotrienols and tocopherol (PTT) does not significantly impact platelet aggregation and activation, coagulation and inflammation in patients with metabolic syndrome, a new randomized controlled trial reveals.
Individuals with type 2 diabetes (T2D) who were hospitalized with nonalcoholic fatty liver disease (NAFLD) had an elevated risk of cardiovascular disease (CVD), and death due to CVD, hepatocellular cancer, and other causes, according to a study presented at EASD 2017.
The novel, G-protein coupled receptor 119 (GPR119) agonist DS-8500a demonstrated dose-dependent glucose-lowering effects and favourable improvements in lipid parameters that extended up to 12 weeks in Japanese patients with type 2 diabetes mellitus (T2D), according to data presented at EASD 2017.